{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T19:20:55Z","timestamp":1790882455074,"version":"4.1.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T00:00:00Z","timestamp":1751500800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T00:00:00Z","timestamp":1751500800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100007051","name":"Uppsala University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007051","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Depression is a debilitating mental health disorder that affects a significant portion of the adolescent population, and 20% of affected youths do not respond to two trials of treatment with antidepressants, i.e. suffer from treatment resistant depression (TRD). Repetitive transcranial magnetic stimulation (rTMS) has demonstrated efficacy in TRD in adults, but its application in the adolescent population remains relatively unexplored. This open label pilot study investigates the safety, feasibility, and potential efficacy of low-frequency (1\u00a0Hz) rTMS over the right dorsolateral prefrontal cortex (DLPFC) for adolescent TRD. Twenty patients, 13\u201318 years old, with treatment resistant unipolar- or bipolar depression were included (inclusion rate 0.9 patients per month) and two dropped out resulting in 18 participants completing the study (attrition rate 0.10). Daily sessions on 20\u201330 consecutive days with 1\u00a0Hz rTMS was administered. A significant decrease in depressive symptoms (decrease from median score of 35 to 23 on Montgomery-Asberg Depression Rating Scale,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.01) and increase in function measures (increase of median score of 45 to 55 on Children\u2019s Global Assessment Scale,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.05) was observed at the end of treatment compared to baseline. However, only one patient reached the response criterium (&lt;\u200950% score in Montgomery-Asberg Depression Rating Scale). Adverse effects such as scalp pain, headache, tiredness and nausea were common but tolerable, and tended to decrease during the course of treatment. In conclusion, the results of this study support feasibility of future larger studies of right frontal low-frequency rTMS for TRD in the adolescent population.\n                  <\/jats:p>","DOI":"10.1186\/s12888-025-07115-5","type":"journal-article","created":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T10:42:00Z","timestamp":1751539320000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Low-frequency repetitive transcranial magnetic stimulation for adolescent treatment resistant depression - a feasibility study"],"prefix":"10.1186","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9758-5348","authenticated-orcid":false,"given":"Jonas","family":"Jester-Broms","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Str\u00f6mbergsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas","family":"Persson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2198-8842","authenticated-orcid":false,"given":"Robert","family":"Bod\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,3]]},"reference":[{"key":"7115_CR1","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1016\/S0140-6736(12)61689-4","volume":"380","author":"CJL Murray","year":"2012","unstructured":"Murray CJL, Vos T, Lozano R, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990\u20132010: a systematic analysis for the global burden of disease study 2010. Lancet Lond Engl. 2012;380:2197\u2013223. https:\/\/doi.org\/10.1016\/S0140-6736(12)61689-4.","journal-title":"Lancet Lond Engl"},{"key":"7115_CR2","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/1741-7015-9-90","volume":"9","author":"E Bromet","year":"2011","unstructured":"Bromet E, Andrade LH, Hwang I, et al. Cross-national epidemiology of DSM-IV major depressive episode. BMC Med. 2011;9:90. https:\/\/doi.org\/10.1186\/1741-7015-9-90.","journal-title":"BMC Med"},{"key":"7115_CR3","doi-asserted-by":"publisher","first-page":"e024939","DOI":"10.1136\/bmjopen-2018-024939","volume":"9","author":"I Alaie","year":"2019","unstructured":"Alaie I, Philipson A, Ssegonja R, et al. Uppsala longitudinal adolescent depression study (ULADS). BMJ Open. 2019;9:e024939. https:\/\/doi.org\/10.1136\/bmjopen-2018-024939.","journal-title":"BMJ Open"},{"key":"7115_CR4","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1002\/da.22777","volume":"35","author":"D Johnson","year":"2018","unstructured":"Johnson D, Dupuis G, Piche J, et al. Adult mental health outcomes of adolescent depression: A systematic review. Depress Anxiety. 2018;35:700\u201316. https:\/\/doi.org\/10.1002\/da.22777.","journal-title":"Depress Anxiety"},{"key":"7115_CR5","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1111\/jcpp.13202","volume":"61","author":"JB Dwyer","year":"2020","unstructured":"Dwyer JB, Stringaris A, Brent DA, Bloch MH. Annual research review: defining and treating pediatric treatment-resistant depression. J Child Psychol Psychiatry. 2020;61:312\u201332. https:\/\/doi.org\/10.1111\/jcpp.13202.","journal-title":"J Child Psychol Psychiatry"},{"key":"7115_CR6","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s00787-019-01341-5","volume":"29","author":"K Boylan","year":"2020","unstructured":"Boylan K, MacQueen G, Kirkpatrick R, et al. A systematic review of interventions for treatment resistant major depressive disorder in adolescents. Eur Child Adolesc Psychiatry. 2020;29:433\u201343. https:\/\/doi.org\/10.1007\/s00787-019-01341-5.","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"7115_CR7","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s40272-014-0088-y","volume":"16","author":"M DeFilippis","year":"2014","unstructured":"DeFilippis M, Wagner KD. Management of Treatment-Resistant depression in children and adolescents. Pediatr Drugs. 2014;16:353\u201361. https:\/\/doi.org\/10.1007\/s40272-014-0088-y.","journal-title":"Pediatr Drugs"},{"key":"7115_CR8","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1016\/S0140-6736(18)30295-2","volume":"391","author":"DM Blumberger","year":"2018","unstructured":"Blumberger DM, Vila-Rodriguez F, Thorpe KE, et al. Effectiveness of theta burst versus high-frequency repetitive transcranial magnetic stimulation in patients with depression (THREE-D): a randomised non-inferiority trial. Lancet. 2018;391:1683\u201392. https:\/\/doi.org\/10.1016\/S0140-6736(18)30295-2.","journal-title":"Lancet"},{"key":"7115_CR9","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/j.brs.2014.07.040","volume":"7","author":"J Brunelin","year":"2014","unstructured":"Brunelin J, Jalenques I, Trojak B, et al. The efficacy and safety of low frequency repetitive transcranial magnetic stimulation for Treatment-resistant depression: the results from a large multicenter French RCT. Brain Stimulat. 2014;7:855\u201363. https:\/\/doi.org\/10.1016\/j.brs.2014.07.040.","journal-title":"Brain Stimulat"},{"key":"7115_CR10","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.clinph.2020.10.003","volume":"132","author":"S Rossi","year":"2021","unstructured":"Rossi S, Antal A, Bestmann S, et al. Safety and recommendations for TMS use in healthy subjects and patient populations, with updates on training, ethical and regulatory issues: expert guidelines. Clin Neurophysiol. 2021;132:269\u2013306. https:\/\/doi.org\/10.1016\/j.clinph.2020.10.003.","journal-title":"Clin Neurophysiol"},{"key":"7115_CR11","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1515\/revneuro-2013-0024","volume":"24","author":"FJ Medina","year":"2013","unstructured":"Medina FJ, T\u00fanez I. Mechanisms and pathways underlying the therapeutic effect of transcranial magnetic stimulation. Rev Neurosci. 2013;24:507\u201325. https:\/\/doi.org\/10.1515\/revneuro-2013-0024.","journal-title":"Rev Neurosci"},{"key":"7115_CR12","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.jad.2021.03.019","volume":"287","author":"H Li","year":"2021","unstructured":"Li H, Cui L, Li J, et al. Comparative efficacy and acceptability of neuromodulation procedures in the treatment of treatment-resistant depression: a network meta-analysis of randomized controlled trials. J Affect Disord. 2021;287:115\u201324. https:\/\/doi.org\/10.1016\/j.jad.2021.03.019.","journal-title":"J Affect Disord"},{"key":"7115_CR13","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1038\/s41386-020-00829-y","volume":"46","author":"PE Croarkin","year":"2021","unstructured":"Croarkin PE, Elmaadawi AZ, Aaronson ST, et al. Left prefrontal transcranial magnetic stimulation for treatment-resistant depression in adolescents: a double-blind, randomized, sham-controlled trial. Neuropsychopharmacology. 2021;46:462\u20139. https:\/\/doi.org\/10.1038\/s41386-020-00829-y.","journal-title":"Neuropsychopharmacology"},{"key":"7115_CR14","doi-asserted-by":"publisher","first-page":"1397706","DOI":"10.3389\/fpsyt.2024.1397706","volume":"15","author":"L Jiao","year":"2024","unstructured":"Jiao L, Chen T, Huang Y, Huang X. Effect analysis of repeated transcranial magnetic stimulation combined with Fluoxetine in the treatment of first-episode adolescent depression. Front Psychiatry. 2024;15:1397706. https:\/\/doi.org\/10.3389\/fpsyt.2024.1397706.","journal-title":"Front Psychiatry"},{"key":"7115_CR15","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.jad.2024.06.054","volume":"361","author":"M Winninge","year":"2024","unstructured":"Winninge M, Cernvall M, Persson J, Bod\u00e9n R. Early symptom improvement and other clinical predictors of response to repetitive transcranial magnetic stimulation for depression. J Affect Disord. 2024;361:383\u20139. https:\/\/doi.org\/10.1016\/j.jad.2024.06.054.","journal-title":"J Affect Disord"},{"key":"7115_CR16","doi-asserted-by":"publisher","first-page":"455","DOI":"10.3870\/zgkf.2015.06.018","volume":"30","author":"H Feng","year":"2015","unstructured":"Feng H, Qin G, Chen J. Early intervention of repetitive low frequency transcranial magnetic stimulation in first episode children with depression. China J Rehab. 2015;30:455\u20136. https:\/\/doi.org\/10.3870\/zgkf.2015.06.018.","journal-title":"China J Rehab"},{"key":"7115_CR17","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.jad.2024.11.001","volume":"370","author":"L-M Gu","year":"2025","unstructured":"Gu L-M, Deng C-J, Shang D-W, et al. Efficacy and safety of low-frequency repetitive transcranial magnetic stimulation in adolescents with first-episode major depressive disorder: A randomized, double-blind, sham-controlled pilot trial. J Affect Disord. 2025;370:190\u20137. https:\/\/doi.org\/10.1016\/j.jad.2024.11.001.","journal-title":"J Affect Disord"},{"key":"7115_CR18","doi-asserted-by":"publisher","first-page":"72","DOI":"10.3969\/j.issn.1001-568X.2019.10.0025","volume":"33","author":"L Han","year":"2019","unstructured":"Han L, Gao C. Analysis on the effect of repeated low frequency transcranial magnetic stimulation on first-episode depression among children. Chin Prim Health Care. 2019;33:72\u20133. https:\/\/doi.org\/10.3969\/j.issn.1001-568X.2019.10.0025.","journal-title":"Chin Prim Health Care"},{"key":"7115_CR19","doi-asserted-by":"publisher","first-page":"85","DOI":"10.3969\/j.issn.1009-6574.2017.02.003","volume":"17","author":"L Zhang","year":"2017","unstructured":"Zhang L, Huang S, Shao X. Treatment effects of low frequency repetitive transcranial magnetic stimulation(rTMS) on adolescent patients with first-episode depression: a controlled clinical study. J Neurosci Ment Health. 2017;17:85\u20138. https:\/\/doi.org\/10.3969\/j.issn.1009-6574.2017.02.003.","journal-title":"J Neurosci Ment Health"},{"key":"7115_CR20","doi-asserted-by":"publisher","first-page":"1111754","DOI":"10.3389\/fpsyt.2023.1111754","volume":"14","author":"W Zheng","year":"2023","unstructured":"Zheng W, Lan X-J, Qin Z-J, et al. Low-frequency repetitive transcranial magnetic stimulation for children and adolescents with first-episode and drug-na\u00efve major depressive disorder: A systematic review. Front Psychiatry. 2023;14:1111754. https:\/\/doi.org\/10.3389\/fpsyt.2023.1111754.","journal-title":"Front Psychiatry"},{"key":"7115_CR21","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1097\/YCT.0000000000000739","volume":"37","author":"T Zhang","year":"2021","unstructured":"Zhang T, Zhu J, Wang J, et al. An Open-label trial of adjuvant High-frequency left prefrontal repetitive transcranial magnetic stimulation for treating suicidal ideation in adolescents and adults with depression. J ECT. 2021;37:140\u20136. https:\/\/doi.org\/10.1097\/YCT.0000000000000739.","journal-title":"J ECT"},{"key":"7115_CR22","doi-asserted-by":"publisher","first-page":"313","DOI":"10.4088\/JCP.09m05305whi","volume":"71","author":"DV Sheehan","year":"2010","unstructured":"Sheehan DV, Sheehan KH, Shytle RD, et al. Reliability and validity of the Mini international neuropsychiatric interview for children and adolescents (MINI-KID). J Clin Psychiatry. 2010;71:313\u201326. https:\/\/doi.org\/10.4088\/JCP.09m05305whi.","journal-title":"J Clin Psychiatry"},{"key":"7115_CR23","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1093\/ijnp\/pyz021","volume":"22","author":"D Doruk Camsari","year":"2019","unstructured":"Doruk Camsari D, Lewis CP, Sonmez AI, et al. Transcranial magnetic stimulation markers of antidepressant treatment in adolescents with major depressive disorder. Int J Neuropsychopharmacol. 2019;22:435\u201344. https:\/\/doi.org\/10.1093\/ijnp\/pyz021.","journal-title":"Int J Neuropsychopharmacol"},{"key":"7115_CR24","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/j.brs.2015.05.008","volume":"8","author":"A Mir-Moghtadaei","year":"2015","unstructured":"Mir-Moghtadaei A, Caballero R, Fried P, et al. Concordance between BeamF3 and MRI-neuronavigated target sites for repetitive transcranial magnetic stimulation of the left dorsolateral prefrontal cortex. Brain Stimulat. 2015;8:965\u201373. https:\/\/doi.org\/10.1016\/j.brs.2015.05.008.","journal-title":"Brain Stimulat"},{"key":"7115_CR25","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/S0006-3223(03)00231-2","volume":"53","author":"M Fava","year":"2003","unstructured":"Fava M. Diagnosis and definition of treatment-resistant depression. Biol Psychiatry. 2003;53:649\u201359. https:\/\/doi.org\/10.1016\/S0006-3223(03)00231-2.","journal-title":"Biol Psychiatry"},{"key":"7115_CR26","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1177\/1740774512465064","volume":"9","author":"J Younger","year":"2012","unstructured":"Younger J, Gandhi V, Hubbard E, Mackey S. Development of the Stanford expectations of treatment scale (SETS): A tool for measuring patient outcome expectancy in clinical trials. Clin Trials. 2012;9:767\u201376. https:\/\/doi.org\/10.1177\/1740774512465064.","journal-title":"Clin Trials"},{"key":"7115_CR27","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1192\/bjp.134.4.382","volume":"134","author":"SA Montgomery","year":"1979","unstructured":"Montgomery SA, \u00c5sberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry. 1979;134:382\u20139. https:\/\/doi.org\/10.1192\/bjp.134.4.382.","journal-title":"Br J Psychiatry"},{"key":"7115_CR28","unstructured":"R Core Team. R: A Language and. Environment for Statistical Computing; 2024. https:\/\/www.r-project.org\/."},{"key":"7115_CR29","unstructured":"Tomczak E, Tomczak M. The need to report effect size estimates revisited. An overview of some recommended measures of effect size. TRENDS Sport Sci. 2014;1(21):19\u201325."},{"key":"7115_CR30","doi-asserted-by":"publisher","first-page":"80","DOI":"10.2307\/3001968","volume":"1","author":"F Wilcoxon","year":"1945","unstructured":"Wilcoxon F. Individual comparisons by ranking methods. Biom Bull. 1945;1:80. https:\/\/doi.org\/10.2307\/3001968.","journal-title":"Biom Bull"},{"key":"7115_CR31","doi-asserted-by":"publisher","unstructured":"Bates D, M\u00e4chler M, Bolker B, Walker S. Fitting linear Mixed-Effects models using lme4. J Stat Softw. 2015;67. https:\/\/doi.org\/10.18637\/jss.v067.i01.","DOI":"10.18637\/jss.v067.i01"},{"key":"7115_CR32","doi-asserted-by":"publisher","unstructured":"Kuznetsova A, Brockhoff PB, Christensen RHB. LmerTest package: tests in linear mixed effects models. J Stat Softw. 2017;82. https:\/\/doi.org\/10.18637\/jss.v082.i13.","DOI":"10.18637\/jss.v082.i13"},{"key":"7115_CR33","unstructured":"Kassambara A. Ggpubr: ggplot2. Based Publication Ready Plots; 2023. https:\/\/cran.r-project.org\/web\/packages\/ggpubr\/index.html."},{"key":"7115_CR34","doi-asserted-by":"publisher","unstructured":"Wickham H. ggplot2: Elegant Graphics for Data Analysis, 2nd ed. Springer International Publishing: Imprint: Springer, Cham. 2016. https:\/\/doi.org\/10.1007\/978-3-319-24277-4.","DOI":"10.1007\/978-3-319-24277-4"},{"key":"7115_CR35","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1097\/01.chi.0000142280.87429.68","volume":"43","author":"N Ghaziuddin","year":"2004","unstructured":"Ghaziuddin N, Kutcher SP, Knapp P. Practice parameter for use of electroconvulsive therapy with adolescents. J Am Acad Child Adolesc Psychiatry. 2004;43:1521\u201339. https:\/\/doi.org\/10.1097\/01.chi.0000142280.87429.68.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"7115_CR36","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1111\/acps.13260","volume":"143","author":"I Turkoz","year":"2021","unstructured":"Turkoz I, Alphs L, Singh J, et al. Clinically meaningful changes on depressive symptom measures and patient-reported outcomes in patients with treatment-resistant depression. Acta Psychiatr Scand. 2021;143:253\u201363. https:\/\/doi.org\/10.1111\/acps.13260.","journal-title":"Acta Psychiatr Scand"},{"key":"7115_CR37","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/npp.2012.237","volume":"38","author":"MT Berlim","year":"2013","unstructured":"Berlim MT, Van den Eynde F, Jeff Daskalakis Z. Clinically meaningful efficacy and acceptability of low-frequency repetitive transcranial magnetic stimulation (rTMS) for treating primary major depression: a meta-analysis of randomized, double-blind and sham-controlled trials. Neuropsychopharmacol Off Publ Am Coll Neuropsychopharmacol. 2013;38:543\u201351. https:\/\/doi.org\/10.1038\/npp.2012.237.","journal-title":"Neuropsychopharmacol Off Publ Am Coll Neuropsychopharmacol"}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-025-07115-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12888-025-07115-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-025-07115-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T10:04:18Z","timestamp":1781604258000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12888-025-07115-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,3]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7115"],"URL":"https:\/\/doi.org\/10.1186\/s12888-025-07115-5","relation":{},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,3]]},"assertion":[{"value":"28 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures contributing to this work comply with the ethical standards of the relevant national and institutional committees on human experimentation and with the Helsinki Declaration of 1975, as revised in 2008. The study protocol was approved by the Swedish Ethical Review Authority (reference number 2021\u201303712). Informed written consent to participate in the current study was obtained from parents or legal guardian for all of the included patients.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"679"}}